Skip to Content

Karl Semaan

Karl Semaan, MD, MSc, is a Research Fellow at the Dana-Farber Cancer Institute in Boston, USA as well as a Computational Biologist with an interest in epigenomics. His primary focus is on investigating cancer mechanisms of resistance to treatment using plasma cell-free DNA epigenomic profiling.

Back to top